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ORIGINAL ARTICLE
Motion frozen 18F-FDG cardiac PET
Ludovic Le Meunier, PhD,a,c Piotr J. Slomka, PhD,a,b Damini Dey, PhD,a,b
Amit Ramesh, MSc,b Louis E. J. Thomson, MBChB, FRACP,a
Sean W. Hayes, MD,a John D. Friedman, MD,a Victor Cheng, MD,a
Guido Germano, PhD,a,b and Daniel S. Berman, MDa,b
Background. PET reconstruction incorporating spatially variant 3D Point Spread Function
(PSF) improves contrast and image resolution. ‘‘Cardiac Motion Frozen’’ (CMF) processing
eliminates the influence of cardiac motion in static summed images. We have evaluated the
combined use of CMF- and PSF-based reconstruction for high-resolution cardiac PET.
Methods. Static and 16-bin ECG-gated images of 20 patients referred for 18F-FDG myo-
cardial viability scans were obtained on a Siemens Biograph-64. CMF was applied to the gated
images reconstructed with PSF. Myocardium to blood contrast, maximum left ventricle (LV)
counts to defect contrast, contrast-to-noise (CNR) and wall thickness with standard recon-
struction (2D-AWOSEM), PSF, ED-gated PSF, and CMF-PSF were compared.
Results. The measured wall thickness was 18.9 ± 5.2 mm for 2D-AWOSEM, 16.6 ± 4.5 mm
for PSF, and 13.8 ± 3.9 mm for CMF-PSF reconstructed images (all P < .05). The CMF-PSF
myocardium to blood and maximum LV counts to defect contrasts (5.7 ± 2.7, 10.0 ± 5.7) were
higher than for 2D-AWOSEM (3.5 ± 1.4, 6.5 ± 3.1) and for PSF (3.9 ± 1.7, 7.7 ± 3.7) (CMF vs all
other, P < .05). The CNR for CMF-PSF (26.3 ± 17.5) was comparable to PSF (29.1 ± 18.3), but
higher than for ED-gated dataset (13.7 ± 8.8, P < .05).
Conclusion. Combined CMF-PSF reconstruction increased myocardium to blood contrast,
maximum LV counts to defect contrast and maintained equivalent noise when compared to static
summed 2D-AWOSEM and PSF reconstruction. (J Nucl Cardiol 2011;18:259–66.)
Key Words: Metabolism: PET Æ cardiac motion frozen Æ point spread function Æ
cardiac imaging
INTRODUCTION
The cardiac PET image quality can be limited by
several factors including the intrinsic performance of the
PET scanner. The distortions in the photon detection
process due to the circular geometry of PET scanners and
consequent increased tilting of the crystals off the center
of the field of view (FOV) have a negative impact on the
spatial resolution and on the noise in the reconstructed
images. The recently introduced High-Definition Positron
Emission Tomography (HDPET) technology (Siemens
Healthcare Molecular Imaging, Knoxville, TN), recon-
struction, significantly improves image spatial resolution
and signal-to-noise ratio in the images using spatially
variant detector spatial response with 3D-specific Point
Spread Function (PSF) during the reconstruction step.1,2
This type of resolution recovery reconstruction was
introduced by other vendors as well and is termed in this
manuscript as PSF reconstruction.
However, even with the improvements of PSF-
based reconstruction in terms of spatial resolution and
noise control, high-resolution myocardial imaging still
faces the challenges of cardiac and respiratory motions,
which degrade the static image quality by blurring the
image. To address cardiac motion, the ‘‘Cardiac Motion
Frozen’’ (CMF) technique has been developed previ-
ously by Slomka et al3 for myocardial perfusion single-
photon emission computed tomography (SPECT) ima-
ges. This algorithm tracks the motion of the left
ventricle (LV) in cardiac gated images, and then adjusts
all cardiac phases to one phase (typically end diastolic)
resulting in an image free of cardiac motion.
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To our knowledge, CMF has never been evaluated
in PET cardiac images. We hypothesized that CMF
technique can further improve image quality of cardiac
PET above that offered by resolution recovery as
recently described.2 In this study, the authors tested this
hypothesis in cardiac PET with Fluorine-18 fluorode-
oxyglucose (18F-FDG).4 We describe the technique, and
evaluate the improvement of CMF processing on image
contrast, noise, myocardial wall thickness, and detect-
ability of myocardial defects.
MATERIALS AND METHODS
PET Acquisition and Reconstruction
All images were acquired on a Siemens Biograph-64
TruePoint PET/CT with the TrueV option. This 3D system
consists of a 64-slice CT and a PET scanner with 4 rings of
Lutetium Oxyorthosilicate (LSO) detectors with a detector
element dimensions of 4 9 4 9 20 mm3.5 The image plane
spacing is 2 mm. The PET axial and transaxial FOV are 216
and 605 mm respectively. The coincidence time window and
the energy window are respectively 4.5 ns and 425-650 keV.
The data was acquired in list mode format. A full description
of the system performance can be found in.6
Patient Acquisition
The authors retrospectively evaluated 18F-FDG myocar-
dial viability patient studies performed for clinical indications.
Investigational Review Board (IRB) permission was obtained
for retrospective analysis of this data. The overall study pop-
ulation consisted of 20 consecutive patients (16 males and 4
females) referred for myocardial viability assessment. Details
about our patient cohort can be found in Table 1.
After at least 4 hours of fasting, 370 MBq of 18F-FDG
was injected intravenously to all patients. A 60-minute uptake
phase followed the injection. After a 2.8 second standard
topogram acquisition (120 kVp), the patient underwent a CT
scan for attenuation correction (CTAC) using the following
parameters: spiral mode, slice thickness 3.0 mm, total scan
time 3.36 s, pitch 1.5, rotation time 0.5 s, collimation
24 9 1.2 mm, tube voltage 120 kVp, tube current 11 mAs.
The estimated radiation dose for this CTAC acquisition was
0.3 mSv. Subsequently, 18F-FDG emission data were acquired
for 1 bed position around the heart (identical to the CT cov-
erage of 210 mm). 3D PET ECG-gated 10-minute acquisition
was performed in list mode. During both the CT and the PET
acquisitions, the patients were instructed to breathe normally.
Reconstruction Protocols
After sorting of the list file, static summed images were
reconstructed with the standard reconstruction technique rou-
tinely used at our institution, 2D-Attenuation Weighted
Ordered Subsets Expectation Maximization (AWOSEM) (3
iterations and 8 subsets), and with PSF (4 iterations and 14
subsets).2,7 The number of iterations for the 2 reconstruction
methods varies because of the difference in convergence speed
between 2D-AWOSEM and PSF-based reconstruction. All
the reconstruction parameters were optimized based on a
phantom study in a previous work by our group.2 16-bin ECG-
gated images were generated for PSF. Since the optimal spatial
resolution with HDPET was previously established in the air as
2 mm,1 the authors chose to filter all patient images with a
2 mm Gaussian Filter (GF). The reconstruction matrix was
168 9 168 9 109 with a zoom of 2 and the pixel size was
2 9 2 9 2 mm3. Scatter correction, decay correction, and
random correction were applied to the reconstructed images.
CT-based attenuation correction was employed. When a mis-
alignment was identified, a manual registration matrix with
3D-translations was generated by an experienced technologist
and applied before the final reconstruction process. Both the
original CT-PET alignment and the alignment after manual
registration were checked by an expert imaging physician.
Manual registration between PET and CT was applied before
reconstruction. Manual CT-PET registration was performed in
5 cases out of the 20.
Cardiac Motion Frozen Principle
CMF processing tracks the motion of the LV in cardiac
gated images and then adjusts all cardiac phases to one phase
(typically at end-diastole (ED)) resulting in an image free of
cardiac motion. ‘‘Motion-freezing’’ is accomplished by motion
tracking of the LV endo- and epicardial borders (Figure 1).
The algorithm generates displacement vectors between each
cardiac phase, and utilizes those vectors to put all the gates in
the ED phase (Figure 1). The result is an image free of cardiac
motion blurring (i.e., with the same spatial resolution of a
single cardiac phase image), but with higher counting statistics
and noise similar to static summed images. This algorithm has
been previously described in details and validated for SPECT
versus invasive angiography in.3
Table 1. Characteristics of the 20 patients
included in this study
Characteristics Mean ± SD Range
Age (years) 62 ± 14 43–93
Weight (kg; lbs) 81 ± 13;
179 ± 29
63–107;
139–235
BMI (kg/m2) 28.5 ± 5.4 22.2–46.4
Diabetes 5/20 na
Prior MI 15/20 na
LV hypertrophy 12/20 na
EF 37 ± 12 21–59
Prevalence of MD 15/20 na
Extent of MD (%) 13.9 ± 15.8 0–47
BMI, Body Mass Index; MI, myocardial infarction; LV, left
ventricle; MD, metabolic defect.
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Image Processing and Analysis
Short axis reorientation and automatic contouring of the
LV in static and gated images were done automatically using
QPET software (Cedars—Sinai Cardiac Package), for which
input were transverse slices of reconstructed PET image.8
CMF image processing technique was then applied to the gated
datasets. The myocardial wall segment analysis was done with
the 17-segment American Heart Association (AHA) model.9
Myocardium to blood contrast and con-
trast-to-noise ratio. Volumes of interest (VOI) over
the LV and the blood pool (significantly larger than the spatial
resolution in the image) were automatically derived based on
the QPET segmentation of the LV. We calculated the contrast
(Cont) between the blood pool and the myocardial wall, and
the contrast-to-noise (CNR) as follows:
Cont ¼ meanðVentricular VOIÞ
mean(Blood VOIÞ
CNR =
meanðVentricular VOIÞ  meanðBlood VOIÞ
RMS Noise(Blood VOI)
;
where RMS_Noise is the root mean square of the noise
as defined by the standard deviation of the blood VOI.
Contrast and CNR were calculated globally and for each
of the 17 AHA-segments, from static summed images
and CMF processed images.
Contrast between defect and maximum
uptake in myocardium (maximum LV counts to
defect contrast). The authors calculated the contrast
between the average of the closest neighbors around the
minimum (27 voxels) in segments with defects, and the aver-
age of the closest neighbors (27 voxels) around the maximum
of the myocardium. The segments with defects were identified
using the original physician report based on standard
2D-AWOSEM images.
Myocardial wall thickness. Using the contours
automatically detected by QPET, the authors estimated the
wall thickness defined as the full width half maximum
(FWHM) of a profile taken on the images at three different
levels of the long axis (basal, mid, and apical) and with two
orientations (septal to lateral and inferior to superior) for a total
of 6 profiles per dataset.
Statistical Analysis
All continuous variables are expressed as mean ± one
standard deviation. Paired t tests were used to compare differ-
ences in paired continuous data, and McNemar’s tests were used
to compare differences in paired discrete data. For unpaired
continuous data, one-way ANOVA was used. All statistical tests
were 2-tailed, and a value of P \ .05 was considered significant.
RESULTS
Myocardial Wall Thickness
The measured wall thickness was significantly
smaller with CMF-PSF reconstruction as compared to
2D-AWOSEM and PSF reconstruction alone. We found
that on average in 20 patients and over the 6 measured pro-
files, the wall thickness was 18.9 ± 5.2 mm for 2D-
AWOSEM, 16.6 ± 4.5 mm for PSF, and 13.8 ± 3.9 mm
for CMF-PSF (all P \ .05). The CMF-PSF wall thickness
was comparable to the thickness of the ED phase in the
Figure 1. Diagram illustrating the principle of Cardiac Motion Frozen technique. (Left) Motion
tracking of the left ventricle using selected points on endo- and epicardial surfaces. (Middle)
Displacement vectors are generated between each cardiac phase. (Right) Starting from those vectors
and using a warping technique, all the counts are put back in the end-diastole (ED) phase. The result
is an image free of cardiac motion with the noise of a summed static image.
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gated dataset reconstructed with PSF (13.3 ± 3.3 mm,
P = NS). The results are summarized in Table 2. An
example of improvements with CMF-PSF reconstruction
in terms of visual image quality can be seen in Figure 2.
Myocardium to Blood Contrast
and Contrast-to-Noise Ratio
The authors found that the myocardium to blood
contrast was significantly increased with CMF process-
ing. The average ratio of counts between the blood pool
and the myocardium for 20 patients increased from
3.5 ± 1.4 for 2D-AWOSEM, 3.9 ± 1.7 for PSF, 3.9 ±
1.6 for ED-gated PSF, to 5.7 ± 2.7 for CMF-PSF
reconstructions (CMF vs all, P \ .05). Meanwhile, the
CNR was also significantly increased with CMF or similar
to summed static image. The CNR was increased by 30%
compared to 2D-AWOSEM, and by 90% compared to
ED-gated image reconstructed with PSF (both P \ .05),
and was similar to PSF (29.1 ± 18.3 vs 26.3 ± 17.5 for
CMF-PSF, P = NS). The full results can be found in
Table 3. An example of the contrast and CNR comparison
for all different reconstructions and processing is shown in
Figure 2. Furthermore, the authors have found that as
expected, the increase of contrast between the blood pool
and the mean in each segment when CMF was used is
significantly correlated to the amount of wall motion per
segment (Figure 3).
Figure 2. Example of an 89-year-old female patient (W = 87 kg [193 lbs], BMI = 32.1) referred
for myocardium viability assessment. Image quality is improved with CMF-PSF (D) compared to
end-diastole (ED) gated PSF (A), 2D-AWOSEM (B) and regular PSF (C). The wall thickness with
CMF-PSF (D) is reduced compared to the summed static images and similar to the ED phase of the
gated images but the noise is drastically decreased compared the gated dataset (A).
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Contrast Between Defect and Maximum
Uptake in Myocardium
In the 20 patients considered in this study, there were
a total of 71 segments identified as abnormal by visual
analysis. With CMF, the authors found a significant
change in the contrast between the average of the closest
neighbors around the minimum in segments with defects
and the average of the closest neighbors around the
maximum of the myocardium. In these segments, the
contrast increased from 6.5 ± 3.1 for 2D-AWOSEM, and
Table 2. Myocardial wall thickness (in mm) measured on profiles taken at basal, mid, and apical levels
from septal (sep) to lateral (lat) and from superior (sup) to inferior (inf)
Wall
thickness
(in mm)
Basal Mid Apical
AverageSep-to-lat Sup-to-inf Sep-to-lat Sup-to-inf Sep-to-lat Sup-to-inf
2D-AWOSEM 17.6 ± 4.6 19.0 ± 3.6 18.3 ± 5.4 19.4 ± 4.6 21.8 ± 8.4 17.0 ± 4.4 18.9 ± 5.2
PSF 16.5 ± 4.5 17.2 ± 3.5 15.8 ± 3.3 17.3 ± 4.7 18.1 ± 7.7 14.8 ± 3.1 16.6 ± 4.5
ED–Gated PSF 12.9 ± 3.8 12.8 ± 2.0 13.7 ± 2.4 13.8 ± 3.6 14.1 ± 4.4 12.7 ± 3.3 13.3 ± 3.3
CMF-PSF 13.0 ± 3.0 14.0 ± 3.6 13.7 ± 2.7 14.2 ± 4.6 14.8 ± 5.9 13.0 ± 4.0 13.8 ± 3.9
Results for 2D-AWOSEM, PSF, end-diastole (ED)-gated PSF and cardiac motion frozen (CMF)-PSF.
All P\ .05 except ED-Gated HDPET versus CMF-HDPET where P = NS.
Figure 3. Segmental contrast increases with CMF against wall motion per segment. For each
patient, the authors calculated the contrast between the blood pool and the mean value in each of the
17 segments. We then calculated the contrast increase for each segment with the use of Cardiac
Motion Frozen technique and the authors plot the results against the segmental wall motion. The
plots show the average over the 20 patients. This figure shows linear correlation between the
segmental contrast increase with CMF, and the corresponding wall motion.
Table 3. Myocardial to blood contrast and contrast-to-noise (CNR) for 2D-AWOSEM, PSF, end-dias-
tole (ED) gated PSF and cardiac motion frozen (CMF) PSF
2D-AWOSEM PSF ED-Gated PSF CMF-PSF
Contrast 3.5 ± 1.4 3.9 ± 1.7 3.9 ± 1.6 5.7 ± 2.7
CNR 21.0 ± 11.9 29.1 ± 18.3* 13.7 ± 8.8 26.3 ± 17.5
P\ .05 for CMF-PSF versus other techniques except for the value marked with *.
Journal of Nuclear Cardiology Le Meunier et al 263
Volume 18, Number 2;259–66 Motion frozen 18F-FDG cardiac PET
from 7.7 ± 3.7 for PSF to 10.0 ± 5.7 for CMF-PSF
reconstructions (P \ .05). An example illustrating the
improved maximum LV counts to defect contrast is
shown in Figure 4.
DISCUSSION
‘‘CMF’’ image processing technique compensates
for the cardiac motion blur in the static images and has
been shown to improve myocardial perfusion SPECT.3,10
In this study, we have demonstrated that it further
improves the technical cardiac image quality obtained
with PSF reconstruction.
The measured myocardial wall thickness was sig-
nificantly decreased with CMF-PSF (-27.0% compared
to 2D-AWOSEM and -16.9% compared to PSF recon-
struction alone). The average wall thickness (13.8 ±
3.9 mm) for the CMF-PSF reconstruction was compara-
ble to the ED thickness (which has no cardiac motion)
measured on gated PSF-reconstructed images (13.3 ±
3.3 mm) (P = NS). Also, our wall thickness results are
still larger than the average size in humans (10.3 ±
1.2 mm at ED) according to Kaul et al.11
The CNR for the CMF-PSF images was signifi-
cantly increased compared to 2D-AWOSEM, but not
compared to PSF reconstruction without CMF, for
which the results were equivalent. However, the CNR
was significantly improved with CMF-PSF and com-
pared to the ED phase of gated PSF reconstruction.
Increased contrast and equivalent CNR compared to
static reconstructions, and wall thickness comparable to
ED-gated images lead to a better image quality in gen-
eral with CMF processing, which can easily be seen in
the images. Furthermore, the authors have shown that
the contrast between the defects, and a region of interest
around the maximum of the myocardium was signifi-
cantly increased with CMF. An example of a patient
image with a metabolic defect, which is only clearly
visible with CMF processing, and which is likely to exist
based on the patient’s SPECT perfusion image findings
is shown in Figure 4.
As expected, our cohort of patients has a relatively
low EF. It is true that patients with low EF will have
hypokinetic regions benefiting to smaller extent from the
CMF technique. However, they often show both seg-
ments with preserved function and segments with
impaired function. Since the CMF processing technique
uses the wall motion as input, the segment-to-blood
contrast is more increased for the segments with a pre-
served myocardial function than for the segments with
an impaired function (as shown in Figure 3). In conse-
quence, the contrast between the viable segments and
unviable segments is increased with CMF (as shown by
our results).
Figure 4. Example of an 84-year-old patient (W = 76 kg [168 lbs], BMI = 27.1) with a history of
MI. The patient exhibits a non-reversible perfusion defect in the apical lateral region of the
myocardium (Left SPECT perfusion images) as well as a moderate hypokinesis in the same region
of the myocardium. The figure shows an example of increase of maximum LV counts to defect
contrast with CMF-PSF (column C) in the horizontal long axis view (top row) and in the 3D
rendering (bottom row). The apical lateral metabolic defect (red arrow) was not seen on 2D-
AWOSEM (column A) and not clearly on PSF (column B) images.
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Because of the limited spatial resolution of PET, the
partial volume effect leads to more counts/per pixel in
the systole. The CMF technique has originally been
developed for SPECT, which suffers from similar res-
olution limitations. CMF adds the counts from the
majority of the cardiac cycle after spatial registration to
the ED phase—as opposed to adding the counts in the
cardiac cycle without any adjustments for motion. The
CMF images are not only considered as diastolic ima-
ges, but also as improved summed images. Therefore,
CMF images of the dyskinetic myocardium will have
similar counts as the simply summed image, which
includes all phases (as it is performed in current clinical
practice).
In this study, CMF was only applied to FDG via-
bility studies. The authors did not have access to the raw
perfusion data for those specific patients since most of
them underwent SPECT perfusion imaging in a different
facility. However, CMF processing has been shown
previously to improve the image quality and the diag-
nostic in SPECT perfusion images in3,10. Therefore, for
clinical applications, CMF technique should perhaps be
used both for viability PET and perfusion SPECT when
they are compared for viability assessment. This study
was focused on a pilot application of CMF technique to
high-resolution data demonstrating improved image
quality. The improvement in quality should also be seen
in the future in PET perfusion images using new tracer
like flurpiridaz F18.12,13 However, the authors did not
have data in which both perfusion and viability were
obtained by high resolution PET.
Study Limitations
This study has several limitations. For instance, a
gold standard did not exist for wall thickness of the
myocardium. Also, there was no an external gold stan-
dard to confirm the presence or the absence of defects;
however, in this study the authors focused on demon-
strating the improvement in technical image quality.
Whether the authors achieve results closer to the true
tracer distribution, it remains to be further investigated.
Our cohort of patients had a limited range of BMI,
typical of our patient population. Our sample size was
small (N = 20) and limited to viability studies; further
studies with larger number of patients and PET perfu-
sion images are warranted. CMF images were
reconstructed with 16 gates only. Since 8-bin gating is
often used, the effect of the temporal resolution with the
8-bin gated datasets may need to be evaluated. However,
the initial validation study of CMF did test the differ-
ence between 8 and 16 gated datasets and the results
were comparable.3
CONCLUSIONS
Our study on 18F-FDG viability studies showed that
CMF processing increased myocardial-to-blood contrast
and maximum LV counts to defect contrast while main-
taining equivalent noise when compared to static summed
images reconstructed with standard and modern recon-
struction techniques incorporating resolution recovery.
The significantly decreased myocardial wall thickness
with CMF-PSF led to a better image quality in general.
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